The serum Carbamazepine test measures the levels of Carbamazepine, a commonly used medication as a first-line treatment for both generalized and partial complex seizures and for non-epileptic conditions such as neuropathic pain and others. Healthcare providers utilize this test to identify instances of drug overdose and toxicity, distinguishing them from long-term therapeutic use.